Related Experiment Video
Updated: May 24, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Prediction of warfarin dose: why, when and how?
Niclas Eriksson1, Mia Wadelius
1Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala University Hospital, entrance 61, SE-751 85 Uppsala, Sweden. niclas.eriksson@ucr.uu.se
Pharmacogenomics
|March 3, 2012
Summary
Pharmacogenetics can personalize warfarin dosing by modeling patient factors and genetic variations. Clinical trials are evaluating if these pharmacogenetic models improve upon standard warfarin initiation methods.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacology
Background:
- Warfarin dosing requires careful management due to its narrow therapeutic index.
- Individual patient response to warfarin varies significantly.
- Pharmacogenetics offers a promising approach to optimize warfarin therapy.
Purpose of the Study:
- To provide a comprehensive overview of warfarin pharmacogenetics.
- To discuss the role of genetic variations (CYP2C9, VKORC1) in warfarin dosing.
- To review existing and emerging prediction models for warfarin dose individualization.
Main Methods:
- Literature review of basic warfarin pharmacology.
- Analysis of factors influencing warfarin dose requirements.
- Examination of various pharmacogenetic prediction models for warfarin.
Main Results:
- Genetic variations in CYP2C9 and VKORC1 are major determinants of warfarin dose.
- Clinical factors combined with genetic data improve dose prediction accuracy.
- Ongoing clinical studies are assessing the superiority of pharmacogenetic dosing.
Conclusions:
- Pharmacogenetic warfarin dosing holds significant potential for individualized therapy.
- Accurate dose prediction models are crucial for safe and effective warfarin initiation.
- Further research and clinical validation are essential to integrate pharmacogenetics into routine practice.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...